Moderna (MRNA) Climbs 6% as Firm Eyes Launch of 3 Vaccines

Moderna Inc. (NASDAQ:MRNA) is one of the 10 Stocks With Standout Gains.

Moderna extended its winning streak to a fourth consecutive day on Tuesday, surging 6.27 percent to close at $55.40 apiece, as investors digested the looming launch of three new vaccines over the next two years.

In a statement on the same day, Moderna Inc. (NASDAQ:MRNA) said that it is planning to launch the flu plus COVID, seasonal flu, and norovirus vaccines between 2027 and 2028.

For illustration purposes only. Photo from Unsplash

At the same time, it is expecting important clinical milestones this year, including potential pivotal data readouts for its investigational individualized neoantigen therapy (Intismeran autogene) and a therapeutic for the rare genetic disease propionic acidemia, which could support the possible launch of its first oncology and rare disease products.

In other news, Moderna Inc. (NASDAQ:MRNA) appointed Ester Banque as its new chief commercial officer, effective on Monday, June 15. She is tasked to focus on continuing to build out the company’s global commercial organization, leading execution across product launches, and expanding presence in new markets.

Before joining Moderna Inc. (NASDAQ:MRNA), Banque served as executive vice president and president for US operations at Zoetis, where she led the company’s largest market and was responsible for its US commercial operations, driving growth across key franchises while helping shape the market for future innovation.

While we acknowledge the risk and potential of MRNA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MRNA and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1